Effects of Thiazolidinediones on development of macrovascular complications in type 2 Diabetes Mellitus
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: SERDAREVIC, Lejla (Pharmacy Avicena, Visoko, Bosnia and Herzegovina)
- Co-author(s): Semiz Sabina, S. (University of Sarajevo, Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina)
Type 2 diabetes mellitus (T2DM) is a chronic, metabolic disorder with an increased risk for developing macrovascular complications. In addition to life style modifications, different oral hypoglycemic agents are used to achieve optimal glycemic control in Type 2 diabetic patients. Thiazolidinediones (TZD's), pioglitazone and rosiglitazone, are.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.